| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.001 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |